31K iOS Apps Tracked Updated 1 min ago Revenue Forecasts
Add an app Create Account Sign In
Home
iOS Apps
iOS Apps LIVE
All iOS Apps 31K Games Productivity Health & Fitness Finance Photo & Video Social Networking
Android Apps
Android Apps LIVE
All Android Apps 1.5M Tools Games Entertainment Photography Finance Education Music & Audio Personalization

Vulvovaginal Candidiasis

Vulvovaginal Candidiasis
Share:
50
Quality Score
Solid

Vulvovaginal Candidiasis

by ISSVD
Low confidence
5.0 App Store rating
✍️ Bumetric analysis
“

Vulvovaginal Candidiasis is an iOS app from ISSVD in the Education category, currently rated 5.0★ across 1 ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.

Quality Score is 50: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast
● Right now
$833
per month
→
12-mo forecast
$728 – $2624
per month
→
24-mo forecast
$675 – $6071
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
  • Title & subtitle keyword fit
  • Description hook & conversion structure
  • Screenshots, ratings, reviews strategy
Run free AI audit →
Typical impact: +2-5× organic installs
🔔Notify me when this app's revenue changes by

📊 Performance Tracking LIVE

5 snapshots on record
idle
0%
Rating
5.0
Reviews
1 reviews
Forecast Revenue / mo
$833
Snapshots tracked
5
since Mar 2026
ONE-TIME · BUILD 💰 Estimated build cost
$125K
↳ What it cost to build · not monthly revenue
Likely range $95K – $170K
$25K · MVP floor $100K · indie scale $500K+ · studio build
📈 Slow ROI — current MRR is well below build cost

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes
🧱 MVP baseline (design + 1-store ship) +$28K
📱 5 unique screens × $4.5K +$22K
⚙ Education complexity ×1.20 +$10K
⚙ 10.5y maintenance × ~1-person team +$62K
Total estimate $125K
ONE-TIME · EXIT VALUE 💵 Estimated acquisition value
$15K
↳ What it would sell for · not monthly revenue
Marketplace range $15K – $20K · 20× MRR multiple
💸 ~0.1× build cost (under-water)

Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.

How the multiple was built
📺 Ad-supported base 15× MRR
📅 10.5y proven track record +20%
⭐ ★ rating ≥ 4.7 (premium) +15%
🏷 Education category multiple +6%
⭐ Small user base (<1K ratings) -8%
Final multiple 20× MRR
🛠 Estimated tech stack
🍎
Native iOS (Swift / UIKit)
High confidence · 80%
Also possible
Native iOS (SwiftUI)

Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.

Signals we read
📦 App bundle size 19 MB
🏷 Category context Education
📦 Compact iOS bundle → Native Swift / UIKit (pre-2020 era)
💀 Maintenance status
Likely abandoned
95%
Last shipped 2019-04-04 · 2737 days ago
0 · Active 50 · At risk 100 · Abandoned

Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.

Risk signals
📅 7y+ since last update Likely abandoned
👥 Small user base (1 ratings) + 10.5y old +10% (solo-project pattern)
• 10y old + 1y+ no update +5% (API deprecation drift)
Verdict Likely abandoned
🔬

How we forecast this revenue

LOW CONFIDENCE
Baseline
$833/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$709 – $1.7K
12 months
$728 – $2.6K
24 months
$675 – $6.1K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊

BU Investment Matrix

Pre-traction · 37/100INDIE TIERlimited signal
GrowthFounderQualityRevenueMonetiz.MoatMarketSafety
Growth Velocity
5.0
Founder Strength
3.3
Product Quality
4.0
Revenue Strength
2.9
Monetization Maturity
1.0
Defensibility
4.5
Market Position
2.0
Operational Safety
7.0
  • 💰 Revenue: Marginal — $333 - $2082/mo · INDIE tier · medium confidence, trajectory unclear.
  • ⭐ Quality: 5.0★ across 1 reviews — weak — significant quality concerns.
  • 📍 Market: Not yet charting in any of the 9 monitored markets.
  • 📈 Growth: ⚠ last update 2737d ago — possibly dormant.
  • ⚠️ Risk: Moderate — dormant (2737d since update).
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $14K-$26K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:

💰 Forecast Revenue / mo

MODEL
Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
Paid app ($4.99)METRIC
+$2,800
Excellent rating (5.0★)METRIC
+$2,200
Mature app (10y old)METRIC
+$1,500
Pre-traction phase (1 ratings)METRIC
−$300
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📈 Reviews Growth

LIVE
Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE
Average rating evolution. Updates with each new review batch.

🆕 What's New · v1.3

Updated treatment recommendations.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name
Vulvovaginal Candidiasis
Developer
ISSVD
Bundle ID
Not found
App Store URL
Open in App Store
Category
Education
Content rating
17+
Languages
EN, ES

Company

Website
Not found
Tagline
Today
Description
Find apps and games for iPhone, iPad, Mac, and more on the App Store.
Founded
Not found
HQ / Address
Not found
Employees
Not found
Logo
Available

Revenue

Reported revenue signal / mo
Not found
AI revenue estimate / mo
Not found
AI annual estimate
Not found
Model estimate / mo
$833/mo
Top-grossing rank
Not found
All-time revenue
Not found
Pricing
Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

The Vulvovaginal Candidiasis (Candida, Yeast): Tips for Diagnosis and Treatment app is designed for health care professionals (and informed patients) to easily distinguish the many types of yeast infections and multiple treatment options available.

The app is designed to be used in conjunction with patient visits to assist with finding the best treatment plan for individual patients. It includes patient education materials that can be emailed directly to patients.
App Specs
🔐 Own this app? Claim & verify MRR →
💾 19 MB🔞 17+📱 iOS 8.0+🔖 v1.3🔄 updated 7y ago🌐 EN, ES📂 Education💰 Paid🚀 Launched 2016 (10y old)
🌍

Multi-Country Performance

Available in 9 of 9 monitored markets
MarketRatingReviewsCurrent version
🇦🇺 AU0★0—
🇧🇷 BR0★0—
🇨🇦 CA0★0—
🇩🇪 DE0★0—
🇫🇷 FR0★0—
🇬🇧 GB0★0—
🇮🇳 IN0★0—
🇯🇵 JP0★0—
🇺🇸 US5★15★ this version
🔔

Track this app’s revenue

FREE
Get an email when revenue moves by your threshold. No spam, unsubscribe in one click.

📝 Description

95
BU Score · Transcendent

Similar apps in Education

ISee zeigt Beeinträchtigungen durch Sehbehinderung
$620/mo
★ 1.01
Biomedical Engineering (BME)
$562/mo
★ 1.01
Dentally
$130/mo
★ 1.01
Drip Rate Infusion Calculator
$833/mo
★ 5.01
Med Term Review
$833/mo
★ 5.01
A k-Space Odyssey
$833/mo
★ 5.01
About this analysis
ZCAnalyzed by Zakhar Chumak · founder, Bumetric·Full methodology·Low confidence

Why low confidence: only 1 rating · no founder-verified revenue (model estimate only) · revenue figure is directional only.

📌 Final verdict — read this before you trust the numbers above

Vulvovaginal Candidiasis is a very early-stage iOS app in the education space with weak public traction — only 1 rating, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.

Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.

❓ Frequently Asked Questions

7 answers · auto-generated from this app's public data
How much does Vulvovaginal Candidiasis make per month?▴
Low-confidence model estimate. Vulvovaginal Candidiasis has only 1 App Store rating, so our revenue model has very little signal to work with — treat the ~$833/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like Vulvovaginal Candidiasis?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is Vulvovaginal Candidiasis built with?▴
Our heuristic places Vulvovaginal Candidiasis on the Native iOS (Swift / UIKit) stack (High confidence, 80%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Native iOS (SwiftUI).
Is Vulvovaginal Candidiasis still actively maintained?▴
Maintenance status: Likely abandoned (95% abandonment risk). Last shipped version was 7+ years ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
When was Vulvovaginal Candidiasis last updated?▴
Vulvovaginal Candidiasis last shipped a new version on 2019-04-04 — more than 7 year(s) ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes Vulvovaginal Candidiasis?▴
Vulvovaginal Candidiasis is published by ISSVD on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Vulvovaginal Candidiasis's BU Score?▴
Vulvovaginal Candidiasis has a BU Score of 50/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.